Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine rich repeat containing 37 member A9, pseudogene (LRRC37A9P) is a non-protein-coding pseudogene located on chromosome 17 in humans[1][3]. Pseudogenes like LRRC37A9P are typically remnants of previously functional genes and do not encode functional proteins. While some pseudogenes can play regulatory roles at the RNA level (such as serving as miRNA decoys or generating regulatory non-coding RNAs), LRRC37A9P is not known to function as a therapeutic target and lacks established biological or disease involvement[5][7]. It is not recognized as a receptor, enzyme, transporter, or any other druggable category, and it is not referenced as interacting with drugs or used as a biomarker. Key point: LRRC37A9P is a pseudogene and is not a therapeutic target, receptor, enzyme, or transporter. It may have regulatory RNA functions typical of pseudogenes, but there is no evidence for specific disease association, drug interaction, or biomarker use[1][3][5][7].
None (no drugs target pseudogene LRRC37A9P); general pseudogene mechanisms include regulatory RNA effects
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine rich repeat containing 37 member A9, pseudogene (LRRC37A9P).